Nobukazu Fujimoto

21PUBLICATIONS
42CO-AUTHORS
Memory and attentionRespiratory diseasesCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (21)

|Jul 10, 2026
Reply to: "Beyond Response Rates: Interpreting Long-Term Benefit in CheckMate 743" and "Beyond Statistical Significance: Methodological Fragility and Censoring Bias in the 5-Year Update of CheckMate 743".

|Feb 20, 2026
Adenocarcinoma of the Lung With Metastasis to the Small Intestine: Case Report.

Moeko Ota, Naofumi Hara, Ryo Kato

|Oct 27, 2025
Brain Atrophy and Leukoencephalopathy Following Tarlatamab: Case Report.

Kiriko Onishi, Toki Kitano, Yusuke Fujioka

|May 23, 2025
KEYNOTE-A17: First-Line Pembrolizumab Plus Cisplatin-Pemetrexed in Japanese Participants With Advanced Pleural Mesothelioma.

Takashi Kijima, Terufumi Kato, Yasushi Goto

|Dec 17, 2024
Frequency and Significance of Body Weight Loss During Immunochemotherapy in Patients with Advanced Non-Small Cell Lung Cancer.

Masataka Taoka, Eiki Ichihara, Toshihide Yokoyama

|Sep 03, 2024
Real-world safety of nivolumab in patients with malignant pleural mesothelioma in Japan: post-marketing surveillance study.

Nobukazu Fujimoto, Ayumi Akamatsu, Chikara Honda

Pageof 4

Frequent Collaborators

2 joint publications

Takashi Kijima

2 joint publications

Katsuyuki Hotta

1 joint publications

Kazuhiko Nakagawa

1 joint publications

Yuichiro Takeda